Form 4: Aura Biosciences Executive Receives Stock Grant
Insider Transaction (Form 4)
Erica Kratz, Chief Reg. & Quality Officer of Aura Biosciences, Inc., reported multiple transactions in common stock on September 1, 2026.
Summary
- Grant/award: acquired 100,885 Common Stock on September 1, 2026; holds 100,885 after (Direct).
- Grant/award: acquired 199,115 Stock Option (Right to Buy) on September 1, 2026; holds 199,115 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Erica Kratz — Officer (Chief Reg. & Quality Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Grant/award | Common Stock | 100,885 | — | — | 100,885 |
| 2026-09-01 | Grant/award | Stock Option (Right to Buy) | 199,115 | — | — | 199,115 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Grant/award (100,885 shares) |
| 2026-09-01 | Grant/award (199,115 shares) |
Keywords
insider transaction, Form 4, AURA, Aura Biosciences, Inc., neutral, Erica Kratz
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.